These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28431913)

  • 1. Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
    Morin L; Vetrano DL; Grande G; Fratiglioni L; Fastbom J; Johnell K
    J Am Med Dir Assoc; 2017 Jun; 18(6):551.e1-551.e7. PubMed ID: 28431913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.
    Matlow JN; Bronskill SE; Gruneir A; Bell CM; Stall NM; Herrmann N; Seitz DP; Gill SS; Austin PC; Fischer HD; Fung K; Wu W; Rochon PA
    J Am Geriatr Soc; 2017 Jul; 65(7):1535-1542. PubMed ID: 28369696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany.
    Rausch C; Hoffmann F
    Eur J Clin Pharmacol; 2020 Jun; 76(6):877-885. PubMed ID: 32219538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
    Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
    Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.
    Morin L; Wastesson JW; Laroche ML; Fastbom J; Johnell K
    Palliat Med; 2019 Sep; 33(8):1080-1090. PubMed ID: 31172885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of medications of questionable benefit in advanced dementia.
    Tjia J; Briesacher BA; Peterson D; Liu Q; Andrade SE; Mitchell SL
    JAMA Intern Med; 2014 Nov; 174(11):1763-71. PubMed ID: 25201279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.
    Morin L; Beaussant Y; Aubry R; Fastbom J; Johnell K
    J Am Geriatr Soc; 2016 Sep; 64(9):1851-7. PubMed ID: 27459579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the level of education associated with transitions between care settings in older adults near the end of life? A nationwide, retrospective cohort study.
    Kelfve S; Wastesson J; Fors S; Johnell K; Morin L
    Palliat Med; 2018 Feb; 32(2):366-375. PubMed ID: 28952874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication appropriateness for patients with dementia approaching the end of their life.
    Chuang HY; Wen YW; Chen LK; Hsiao FY
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():65-74. PubMed ID: 28436189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
    Grande G; Morin L; Vetrano DL; Fastbom J; Johnell K
    Drugs Aging; 2017 Jul; 34(7):529-533. PubMed ID: 28536907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication use in nursing home residents with advanced dementia.
    Blass DM; Black BS; Phillips H; Finucane T; Baker A; Loreck D; Rabins PV
    Int J Geriatr Psychiatry; 2008 May; 23(5):490-6. PubMed ID: 17944007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
    Morin L; Todd A; Barclay S; Wastesson JW; Fastbom J; Johnell K
    Cancer; 2019 Jul; 125(13):2309-2317. PubMed ID: 30906987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study.
    Wastesson JW; Morin L; Laroche ML; Johnell K
    J Am Geriatr Soc; 2019 Mar; 67(3):455-462. PubMed ID: 30575952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic management of dementia across settings of care.
    Rattinger GB; Burcu M; Dutcher SK; Chhabra PT; Rosenberg PB; Simoni-Wastila L; Franey CS; Walker LD; Zuckerman IH
    J Am Geriatr Soc; 2013 May; 61(5):723-33. PubMed ID: 23590231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational disparities in antipsychotic drug use among older people with and without dementia in Sweden.
    Wastesson JW; Ringbäck Weitoft G; Johnell K
    Acta Psychiatr Scand; 2015 Jul; 132(1):20-8. PubMed ID: 25532774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
    Morin L; Laroche ML; Vetrano DL; Fastbom J; Johnell K
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1333-1342. PubMed ID: 29934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal care for persons with advanced dementia in the nursing home and home care settings.
    Mitchell SL; Morris JN; Park PS; Fries BE
    J Palliat Med; 2004 Dec; 7(6):808-16. PubMed ID: 15684848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia.
    Axmon A; Kristensson J; Ahlström G; Midlöv P
    Res Dev Disabil; 2017 Mar; 62():50-57. PubMed ID: 28110116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based palliative care is associated with reduced emergency department use by people with dementia in their last year of life: A retrospective cohort study.
    Rosenwax L; Spilsbury K; Arendts G; McNamara B; Semmens J
    Palliat Med; 2015 Sep; 29(8):727-36. PubMed ID: 25783598
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.